GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Molecular Templates Inc (NAS:MTEM) » Definitions » Cyclically Adjusted PB Ratio

Molecular Templates (Molecular Templates) Cyclically Adjusted PB Ratio : 0.11 (As of Apr. 28, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Molecular Templates Cyclically Adjusted PB Ratio?

As of today (2024-04-28), Molecular Templates's current share price is $1.705. Molecular Templates's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $15.62. Molecular Templates's Cyclically Adjusted PB Ratio for today is 0.11.

The historical rank and industry rank for Molecular Templates's Cyclically Adjusted PB Ratio or its related term are showing as below:

MTEM' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.09   Med: 1.44   Max: 5231.25
Current: 0.11

During the past years, Molecular Templates's highest Cyclically Adjusted PB Ratio was 5231.25. The lowest was 0.09. And the median was 1.44.

MTEM's Cyclically Adjusted PB Ratio is ranked better than
88.61% of 641 companies
in the Biotechnology industry
Industry Median: 1.72 vs MTEM: 0.11

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Molecular Templates's adjusted book value per share data for the three months ended in Dec. 2023 was $0.784. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $15.62 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Molecular Templates Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Molecular Templates's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molecular Templates Cyclically Adjusted PB Ratio Chart

Molecular Templates Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.68 0.24

Molecular Templates Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.68 0.61 0.61 0.47 0.24

Competitive Comparison of Molecular Templates's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Molecular Templates's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Molecular Templates's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Molecular Templates's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Molecular Templates's Cyclically Adjusted PB Ratio falls into.



Molecular Templates Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Molecular Templates's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.705/15.62
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Molecular Templates's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Molecular Templates's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.784/129.4194*129.4194
=0.784

Current CPI (Dec. 2023) = 129.4194.

Molecular Templates Quarterly Data

Book Value per Share CPI Adj_Book
201403 -80.596 99.695 -104.626
201406 -78.526 100.560 -101.062
201409 -55.505 100.428 -71.528
201412 -62.896 99.070 -82.164
201503 -46.004 99.621 -59.765
201506 -60.840 100.684 -78.204
201509 -71.364 100.392 -91.999
201512 94.311 99.792 122.311
201603 78.154 100.470 100.673
201606 64.176 101.688 81.677
201609 52.850 101.861 67.149
201612 45.857 101.863 58.263
201703 35.325 102.862 44.445
201706 38.920 103.349 48.738
201709 49.043 104.136 60.950
201712 43.101 104.011 53.630
201803 39.324 105.290 48.336
201806 34.459 106.317 41.947
201809 43.645 106.507 53.034
201812 41.202 105.998 50.306
201903 39.233 107.251 47.343
201906 36.302 108.070 43.474
201909 21.519 108.329 25.708
201912 33.899 108.420 40.465
202003 27.492 108.902 32.672
202006 18.303 108.767 21.778
202009 25.351 109.815 29.877
202012 17.808 109.897 20.971
202103 28.981 111.754 33.562
202106 26.026 114.631 29.383
202109 19.212 115.734 21.484
202112 17.493 117.630 19.246
202203 12.649 121.301 13.496
202206 6.932 125.017 7.176
202209 1.105 125.227 1.142
202212 -4.031 125.222 -4.166
202303 -0.508 127.348 -0.516
202306 -2.310 128.729 -2.322
202309 1.265 129.860 1.261
202312 0.784 129.419 0.784

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Molecular Templates  (NAS:MTEM) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Molecular Templates Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Molecular Templates's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Molecular Templates (Molecular Templates) Business Description

Traded in Other Exchanges
N/A
Address
9301 Amberglen Boulevard, Suite 100, Austin, TX, USA, 78729
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer.
Executives
Maurizio Voi officer: Chief Medical Officer 4 MAGUIRE ROAD, LEXINGTON MA 02421
Biotech Target N V 10 percent owner ARA HILL TOP BUILDING, UNIT A-5, PLETTERIJWEG OOST 1, CURACAO, WILLEMSTAD P8 000000
Sean Mclennan officer: CFO & Treasurer C/O MOLECULAR TEMPLATES, INC., 93010 AMBERGLEN BLVD., SUITE 100, AUSTIN TX 78729
Kevin M. Lalande director, 10 percent owner 201 WEST 5TH STREET, AUSTIN TX 78701
Shv Management Services, Llc 10 percent owner FROST TOWER, 401 CONGRESS AVENUE, SUITE 2950, AUSTIN TX 78701
Gabriela Gruia director C/O TSCAN THERAPEUTICS, INC., 830 WINTER STREET, WALTHAM MA 02451
Jason S. Kim officer: See Remarks 9301 AMBERGLEN BOULEVARD, SUITE 100, C/O MOLECULAR TEMPLATES, INC., AUSTIN TX 78729
Biotech Ag Bb 10 percent owner SCHWERTSTRASSE 6, SCHAFFHAUSEN V8 8200
Longitude Capital Partners Iii, Llc 10 percent owner 800 EL CAMINO, SUITE 220, MENLO PARK CA 94025
Sanders Corazon (corsee) D. director C/O MOLECULAR TEMPLATES, INC., 9301 AMBERGLEN BLVD, SUITE 100, AUSTIN VI 78729
Patrick G Enright 10 percent owner CO LONGITUDE CAPITAL PARTNERS LLC, 800 EL CAMINO REAL, SUITE 220, MENLO PARK CA 94025
Bakker Juliet Tammenoms 10 percent owner LONGITUDE CAPITAL MANAGEMENT CO., LLC, 800 EL CAMINO REAL, SUITE 220, MENLO PARK CA 94025
David Hirsch director, 10 percent owner C/O LONGITUDE CAPITAL PARTNERS, LLC, 800 EL CAMINO REAL, SUITE 220, MENLO PARK CA 94025
Longitude Venture Partners Iii, L.p. 10 percent owner 800 EL CAMINO REAL, SUITE 220, MENLO PARK CA 94025
Scott D Morenstein director C/O CAXTON ALTERNATIVE MANAGEMENT LP, 1330 SIXTH AVENUE, 20TH FLOOR, NEW YORK NY 10019

Molecular Templates (Molecular Templates) Headlines

From GuruFocus

Molecular Templates Announces Debt Payoff and Restructuring

By sperokesalga sperokesalga 06-17-2023

Molecular Templates, Inc. Reports First Quarter 2022 Financial Results

By GuruFocusNews GuruFocusNews 06-11-2022

Molecular Templates, Inc. Reports First Quarter 2022 Financial Results

By GuruFocusNews GuruFocusNews 06-21-2022